SEC Form 4 · accession 0001185185-18-001603
IGC Pharma, Inc. · IGC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sudhakar V Shenoy
Director
Period of report
Aug 28, 2018
Accepted (ET)
Aug 29, 2018 · 6:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326205
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 28, 2018 | A | 215,000 | $0.00 | A | 1,045,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares of Common Stock awarded pursuant to the Issuer's 2018 Omnibus Incentive Plan and the shareholder-approved Special Grant.